Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulinG antibodies, and enhances protective immunity to Blastomyces dermatitidisinfection

Citation
M. Wuthrich et al., Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulinG antibodies, and enhances protective immunity to Blastomyces dermatitidisinfection, INFEC IMMUN, 68(12), 2000, pp. 7172-7174
Citations number
11
Categorie Soggetti
Immunology
Journal title
INFECTION AND IMMUNITY
ISSN journal
00199567 → ACNP
Volume
68
Issue
12
Year of publication
2000
Pages
7172 - 7174
Database
ISI
SICI code
0019-9567(200012)68:12<7172:I1AAAT>2.0.ZU;2-T
Abstract
Cell-mediated immunity is pivotal in host resistance to Blastomyces dermati tidis infection. Immunization of mice with the WI-1 adhesin enhances resist ance against experimental pulmonary infection but elicits features of a mix ed T-helper-cell immune response. Immune mice acquire delayed-type hypersen sitivity (DTH) but also high titers of WI-1-specific immunoglobulin G1 (IgG 1) and IgG2b, a result indicative of T-helper-2 cellular immunity. We repor t that interleukin-12, used as an adjuvant for WI-1 immunization, augments DTH, shifts the balance of the T-helper phenotype toward Th1, and enhances resistance to B. dermatitidis infection.